Please login to the form below
Tonix appoints head of clinical development
Donald Kellerman has experience at Allergan, Map, Inspire and Glaxo Wellcome
Tonix Pharmaceuticals has appointed Dr Donald Kellerman to head the strategy and execution of its clinical programmes.
Dr Kellerman brings 30 years of industry experience to his new role as senior VP, clinical development and regulatory affairs.
This includes his most recent role as VP, scientific affairs for Allergan's inhalation products business. He took on this role after his previous company, Map Pharmaceuticals, was taken over by Allergan in 2013.
At Map, Dr Kellerman served as senior VP, clinical development and medical affairs at Map Pharmaceuticals having joined the company in 2008 from Inspire Pharmaceuticals.
He also has experience at GlaxoWellcome as director of respiratory clinical research.
Featured jobs
-
Consumer Health Account Director
-
Circa £60, 000 Gym and More
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
Senior Medical Writer
-
Great salary and benefits
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
-
Account Director
-
Excellent benefits
-
Medical/ Scientific Director
-
Salary TBC
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
- Director, Market Access / HEOR - North-West
-
Negotiable
- Senior Systematic Review Analyst - Oxford
-
Negotiable
-
Senior Medical Writer
-
Competitive Salary
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
New Business Director - PR
-
Competitive Salary and benefits
-
Account Director
-
£48, 000 - £60, 000
Subscribe to our email news alerts
- The handover: Pfizer reshapes itself for a new era
- AbbVie sues NHS England over hep C procurement
- GSK among businesses wooed as Brexit reckoning nears
- BioMarin eyes 2019 FDA filing for haemophilia A gene therapy
- The handover: Pfizer reshapes itself for a new era
- Novartis: pipeline will generate 60 filings in three years
- Artificial Intelligence In Healthcare Market to Witness Exponential Growth by 2027
- Breathing Exercise Devices Market Intelligence Report Offers Growth Prospects
- Micro-CT Scanners Market 10-Year Market Forecast and Trends Analysis Research Report
- Next Generation Infusion Pump Market Healthy Pace throughout the Forecast during 2017 – 2027
- Wireless Brain Sensors Market Intelligence Report Offers Growth Prospects
- MRI Guided Neurosurgical Ablation Market is Projected to Expand at a CAGR of 4.9% During the Forecast Period 2018–2028 and Reach US$ 216.3 Mn By the End of 2028
PMHub
M3 (EU)
M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...
Latest intelligence
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
- Nudge-nudge, think-think
- Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
- Quality in Care Diabetes 2018: the best in innovative diabetes care
- Awards highlight new evidence-based approaches to improving care...
Quick links
Infographics
